alexa Prolonged Effects of an Anti-Alzheimers Drug, Galantami
e-ISSN: 2321-6190 p-ISSN: 2347-2294

Research & Reviews: Journal of Zoological Sciences
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Prolonged Effects of an Anti-Alzheimers Drug, Galantamine Hydrobromide on Morphometric and Behavioural Aspects of Albino Mice

Borra Nirmala Kumari* and Kuna Yellamma

Department of Zoology, Sri Venkateswara University, Tirupati- 517502, Andhra Pradesh, India.

*Corresponding Author:
Borra Nirmala Kumari
Department of Zoology,
Sri Venkateswara University,
Tirupati- 517502, Andhra Pradesh,
Mobile: +91 9000306169

Received date: 25/07/2013; Accepted da te: 12/08/2013; Published date: 20/08/2013



The present study, emphasises the prolonged effects of an anti-Alzheimer’s drug, Galantamine Hydrobromide, on Morphometric and Behavioural aspects of albino mice in the absence of the disease, AD. One month old male albino mice, Mus musculus (20±2g) were selected as experimental model and Galantamine Hydrobromide as the test drug. The ED50 for GHB was evaluated and was found to be 5mg/kg body weight. This effective dose was given to Experimental groups of mice once in a day up to 180 days continuously. Observations on the general growth aspects such as weight and size and also changes in the behavior pattern of both control and experimental mice were recorded with help of Morris water maze technique. The results on Morphometric aspects revealed that the experimental mice recorded a steady and continuous gain in the body weight with maximum weight (22.15%) gained on 150th day. However, after 150th day, the experimental mice started losing their body weights gradually up to 180th day. As a corollary to these morphometric changes, maximum elevation in performance was noticed on 150th day (56.69%). From then onwards, there was a gradual decline in the performance of the mice. In view of these observations, it was concluded that the memory enhancing drugs meant for treatment of Alzheimer’s disease or any formulated health drinks containing chemicals mimicking the memory enhancing drugs should not be consumed in any form by normal people in general and by young children in particular for a long time for improvement of their cognitive skills.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version